Showing results (211-220 of 751) with videos related to
Sort By:
Pageof 76
Oxidative Medicine and Cellular Longevity|January 31, 2022
A20 Is Increased in Fetal Lung in a Sheep LPS Model of ChorioamnionitisSteffen Kunzmann, Matthias Hütten, Barbara Ottensmeier, et al.Applied Microbiology and Biotechnology|January 25, 2000
Metabolic approaches for the optimisation of recombinant fermentation processesM Cserjan-Puschmann, W Kramer, E Duerrschmid, et al.Anticancer Research|May 1, 2001
Value of tumor M2 (Tu M2-PK) in patients with renal carcinomaG M Oremek, N Sapoutzis, W Kramer, et al.Der Urologe. Ausg. A|October 15, 2013
[Systemic therapy of metastatic bladder cancer.]M Retz, S C Schmid, M W Kramer, et al.European Journal of Biochemistry|December 1, 1982
Bile-salt-binding polypeptides in plasma membranes of hepatocytes revealed by photoaffinity labellingW Kramer, U Bickel, H P Buscher, et al.Frontiers in Cellular and Infection Microbiology|August 13, 2021
Understanding Host-Pathogen Interactions in Acute Chorioamnionitis Through the Use of Animal ModelsAmanda Brosius Lutz, Salwan Al-Nasiry, Boris W Kramer, et al.Molecular and Cellular Pediatrics|April 15, 2016
Can the preterm lung recover from perinatal stress?Matthias C Hütten, Tim G A M Wolfs, Boris W KramerDer Urologe. Ausg. A|March 1, 1993
[Follow-up after kidney transplantation. Sequential functional scintigraphy with technetium-99m-DTPA or technetium-99m-MAG3]W Kramer, R P Baum, E Scheuermann, et al.Current Pharmaceutical Design|May 9, 2012
New pharmacological approaches in infants with hypoxic-ischemic encephalopathyGiuseppe Buonocore, Serafina Perrone, Giovanni Turrisi, et al.Current Pharmaceutical Design|March 6, 2012
New Pharmacological Approaches in Infants with Hypoxic-Ischemic EncephalopathyG Buonocore, G Turrisi, B W Kramer, et al.Pageof 76